Details for: SNRPF

Gene ID: 6636

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: SNRPF

Ensembl ID: ENSG00000139343

Description: small nuclear ribonucleoprotein polypeptide F

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • common myeloid progenitor CL0000049
    CSI 93.66
    rCSI 75.73%
    PRS 12.24
  • hematopoietic stem cell CL0000037
    CSI 85.5
    rCSI 56.83%
    PRS 14.78
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 82.16
    rCSI 74.2%
    PRS 10.96
  • granulocyte monocyte progenitor cell CL0000557
    CSI 80.53
    rCSI 69.73%
    PRS 13.8
  • neural crest cell CL0011012
    CSI 73.55
    rCSI 58.13%
    PRS 8.51
  • stem cell CL0000034
    CSI 69.32
    rCSI 66.84%
    PRS 8.48
  • fallopian tube secretory epithelial cell CL4030006
    CSI 67.4
    rCSI 64.88%
    PRS 12.82
  • early lymphoid progenitor CL0000936
    CSI 67.24
    rCSI 59.06%
    PRS 13.93
  • keratinocyte CL0000312
    CSI 64.45
    rCSI 54.02%
    PRS 14.8
  • intestinal epithelial cell CL0002563
    CSI 62.5
    rCSI 65.33%
    PRS 13.03
  • transit amplifying cell of colon CL0009011
    CSI 62.16
    rCSI 73.01%
    PRS 14.56
  • common dendritic progenitor CL0001029
    CSI 57.05
    rCSI 71.6%
    PRS 15.78
  • fraction A pre-pro B cell CL0002045
    CSI 56.49
    rCSI 64.66%
    PRS 25.41
  • promyelocyte CL0000836
    CSI 56.04
    rCSI 80.83%
    PRS 17.24
  • pro-B cell CL0000826
    CSI 48.62
    rCSI 40.27%
    PRS 12.39
  • mesodermal cell CL0000222
    CSI 47.98
    rCSI 57.59%
    PRS 12.24
  • multi-ciliated epithelial cell CL0005012
    CSI 45.42
    rCSI 45.33%
    PRS 10.58
  • intestine goblet cell CL0019031
    CSI 42.52
    rCSI 37.74%
    PRS 12.4
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 40.72
    rCSI 47.03%
    PRS 10.86
  • plasmablast CL0000980
    CSI 39.54
    rCSI 31.11%
    PRS 14.72
  • promonocyte CL0000559
    CSI 38.82
    rCSI 66.5%
    PRS 16.58
  • pancreatic D cell CL0000173
    CSI 36.86
    rCSI 36.25%
    PRS 13.41
  • epithelial cell of lung CL0000082
    CSI 35.59
    rCSI 29.5%
    PRS 11.68
  • colon epithelial cell CL0011108
    CSI 35.39
    rCSI 37.07%
    PRS 11.53
  • ciliated epithelial cell CL0000067
    CSI 34.62
    rCSI 30.44%
    PRS 8.98
  • radial glial cell CL0000681
    CSI 34.21
    rCSI 47.52%
    PRS 12.75
  • extravillous trophoblast CL0008036
    CSI 33.93
    rCSI 41.98%
    PRS 10.86
  • placental villous trophoblast CL2000060
    CSI 31.89
    rCSI 49.28%
    PRS 11.6
  • transit amplifying cell CL0009010
    CSI 30.97
    rCSI 47.38%
    PRS 20.14
  • peripheral nervous system neuron CL2000032
    CSI 29.29
    rCSI 39.91%
    PRS 11.04
  • enteric smooth muscle cell CL0002504
    CSI 28.6
    rCSI 40.82%
    PRS 13.98
  • colon goblet cell CL0009039
    CSI 26.11
    rCSI 62.08%
    PRS 18.64
  • progenitor cell CL0011026
    CSI 25.44
    rCSI 54.09%
    PRS 21.6
  • large pre-B-II cell CL0000957
    CSI 24.2
    rCSI 69.1%
    PRS 21.44
  • pancreatic acinar cell CL0002064
    CSI 23.82
    rCSI 31.67%
    PRS 13.53
  • common lymphoid progenitor CL0000051
    CSI 23.05
    rCSI 30.81%
    PRS 23.62
  • respiratory hillock cell CL4030023
    CSI 23.04
    rCSI 41.08%
    PRS 20.95
  • pancreatic A cell CL0000171
    CSI 22.16
    rCSI 23.22%
    PRS 13.19
  • epithelial cell CL0000066
    CSI 20.91
    rCSI 32.13%
    PRS 17.64
  • goblet cell CL0000160
    CSI 20.65
    rCSI 19.52%
    PRS 12.94
  • double negative thymocyte CL0002489
    CSI 20.36
    rCSI 14.16%
    PRS 14.51
  • forebrain radial glial cell CL0013000
    CSI 20.12
    rCSI 64.55%
    PRS 18.15
  • glandular epithelial cell CL0000150
    CSI 19.25
    rCSI 50.67%
    PRS 24.2
  • mucous neck cell CL0000651
    CSI 19.18
    rCSI 27.65%
    PRS 19.94
  • deuterosomal cell CL4033044
    CSI 17.49
    rCSI 59.12%
    PRS 20.82
  • mammary gland epithelial cell CL0002327
    CSI 17.47
    rCSI 61.28%
    PRS 22.45
  • microcirculation associated smooth muscle cell CL0008035
    CSI 17.32
    rCSI 50.15%
    PRS 14.02
  • myeloid leukocyte CL0000766
    CSI 16.99
    rCSI 15.67%
    PRS 12.57
  • Hofbauer cell CL3000001
    CSI 16.54
    rCSI 31.22%
    PRS 15.35
  • respiratory suprabasal cell CL4033048
    CSI 16.35
    rCSI 20.97%
    PRS 14.3
  • conventional dendritic cell CL0000990
    CSI 16.1
    rCSI 13.44%
    PRS 36.17
  • muscle cell CL0000187
    CSI 16.01
    rCSI 32.86%
    PRS 29.03
  • transit amplifying cell of small intestine CL0009012
    CSI 15.87
    rCSI 69.68%
    PRS 23.03
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 15.21
    rCSI 36.59%
    PRS 19.58
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 14.93
    rCSI 77.11%
    PRS 24.37
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 14.78
    rCSI 39.83%
    PRS 15.94
  • secretory cell CL0000151
    CSI 13.98
    rCSI 14.59%
    PRS 12.69
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 13.83
    rCSI 17.75%
    PRS 12.04
  • foveolar cell of stomach CL0002179
    CSI 13.14
    rCSI 27.97%
    PRS 19.94
  • precursor B cell CL0000817
    CSI 12.99
    rCSI 11.38%
    PRS 16.43
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 12.39
    rCSI 36.59%
    PRS 15.14
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 12.35
    rCSI 12.59%
    PRS 17.7
  • enterocyte CL0000584
    CSI 12.34
    rCSI 19.89%
    PRS 19.8
  • hepatocyte CL0000182
    CSI 12.17
    rCSI 21.79%
    PRS 11.52
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 12.11
    rCSI 55.05%
    PRS 42.84
  • basal cell of prostate epithelium CL0002341
    CSI 11.67
    rCSI 33.75%
    PRS 27.49
  • naive T cell CL0000898
    CSI 11.63
    rCSI 8.09%
    PRS 17.59
  • stromal cell of ovary CL0002132
    CSI 11.6
    rCSI 31.86%
    PRS 20.42
  • primitive red blood cell CL0002355
    CSI 11.18
    rCSI 60.34%
    PRS 23.16
  • interstitial cell of Cajal CL0002088
    CSI 11.14
    rCSI 14.19%
    PRS 14.39
  • enteroendocrine cell CL0000164
    CSI 10.97
    rCSI 14.99%
    PRS 13.73
  • erythroid progenitor cell CL0000038
    CSI 10.48
    rCSI 60.06%
    PRS 19.14
  • basophil mast progenitor cell CL0002028
    CSI 10.43
    rCSI 55.68%
    PRS 44.61
  • dendritic cell, human CL0001056
    CSI 10.43
    rCSI 16.01%
    PRS 14.46
  • germinal center B cell CL0000844
    CSI 10.29
    rCSI 30.68%
    PRS 30.67
  • eosinophil CL0000771
    CSI 9.98
    rCSI 65.47%
    PRS 31.99
  • kidney epithelial cell CL0002518
    CSI 9.91
    rCSI 18.91%
    PRS 29.15
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 9.75
    rCSI 37.94%
    PRS 20.31
  • pulmonary alveolar type 2 cell CL0002063
    CSI 9.66
    rCSI 14.99%
    PRS 18.84
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 9.3
    rCSI 18.54%
    PRS 20.54
  • paneth cell of epithelium of small intestine CL1000343
    CSI 9.28
    rCSI 26.02%
    PRS 19.12
  • pancreatic stellate cell CL0002410
    CSI 9.07
    rCSI 52.77%
    PRS 18.62
  • memory B cell CL0000787
    CSI 8.97
    rCSI 8.86%
    PRS 46.47
  • retina horizontal cell CL0000745
    CSI 8.89
    rCSI 13.56%
    PRS 11.55
  • skeletal muscle satellite cell CL0000594
    CSI 8.87
    rCSI 25.92%
    PRS 39.73
  • lung ciliated cell CL1000271
    CSI 8.86
    rCSI 10.25%
    PRS 9.07
  • granulocyte CL0000094
    CSI 8.84
    rCSI 13.5%
    PRS 15.65
  • endothelial cell of placenta CL0009092
    CSI 8.83
    rCSI 43.53%
    PRS 16.85
  • perivascular cell CL4033054
    CSI 8.81
    rCSI 12.04%
    PRS 14.06
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 8.73
    rCSI 6.13%
    PRS 32.03
  • intestinal crypt stem cell of colon CL0009043
    CSI 8.64
    rCSI 64.86%
    PRS 22.74
  • colonocyte CL1000347
    CSI 8.53
    rCSI 12.23%
    PRS 16.97
  • myofibroblast cell CL0000186
    CSI 8.49
    rCSI 11.76%
    PRS 17.82
  • respiratory basal cell CL0002633
    CSI 8.44
    rCSI 8.74%
    PRS 14.54
  • pulmonary capillary endothelial cell CL4028001
    CSI 8.29
    rCSI 15.81%
    PRS 19.79
  • plasmacytoid dendritic cell, human CL0001058
    CSI 8.11
    rCSI 5.66%
    PRS 12.99
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 7.99
    rCSI 10.05%
    PRS 52.65
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 7.76
    rCSI 13.71%
    PRS 7.22
  • duct epithelial cell CL0000068
    CSI 7.69
    rCSI 11.25%
    PRS 13.09
  • CD4-positive helper T cell CL0000492
    CSI 7.29
    rCSI 5.52%
    PRS 17.13
  • nasal mucosa goblet cell CL0002480
    CSI -7.9
    rCSI -9.2%
    PRS 18.3%
  • vascular associated smooth muscle cell CL0000359
    CSI -5.7
    rCSI -18.4%
    PRS 15.2%
  • alveolar macrophage CL0000583
    CSI -5.2
    rCSI -8.6%
    PRS 14.4%
  • brush cell of tracheobronchial tree CL0002075
    CSI -2.7
    rCSI -7.9%
    PRS 18.3%
  • central nervous system neuron CL2000029
    CSI -2.0
    rCSI -14.8%
    PRS 6.3%
  • alternatively activated macrophage CL0000890
    CSI -1.1
    rCSI -1.3%
    PRS 18.9%
  • lung neuroendocrine cell CL1000223
    CSI -1.0
    rCSI -1.5%
    PRS 14.2%
  • choroid plexus epithelial cell CL0000706
    CSI -0.9
    rCSI -1.5%
    PRS 9.5%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI -0.3
    rCSI -0.4%
    PRS 21.5%
  • glial cell CL0000125
    CSI -0.3
    rCSI -1.1%
    PRS 12.6%
  • uterine smooth muscle cell CL0002601
    CSI -0.2
    rCSI -1.4%
    PRS 64.5%
  • centrilobular region hepatocyte CL0019029
    CSI 0.0
    rCSI 0.1%
    PRS 19.9%
  • blood vessel smooth muscle cell CL0019018
    CSI 0.1
    rCSI 0.6%
    PRS 12.8%
  • peptic cell CL0000155
    CSI 0.1
    rCSI 0.9%
    PRS 36.3%
  • P/D1 enteroendocrine cell CL0002268
    CSI 0.1
    rCSI 0.6%
    PRS 30.6%
  • osteoblast CL0000062
    CSI 0.2
    rCSI 3.7%
    PRS 74.1%
  • cytotoxic T cell CL0000910
    CSI 0.2
    rCSI 1.2%
    PRS 18.1%
  • lung pericyte CL0009089
    CSI 0.3
    rCSI 0.7%
    PRS 14.8%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.3
    rCSI 1.0%
    PRS 7.8%
  • helper T cell CL0000912
    CSI 0.4
    rCSI 0.5%
    PRS 17.3%
  • lung microvascular endothelial cell CL2000016
    CSI 0.4
    rCSI 7.1%
    PRS 38.8%
  • late pro-B cell CL0002048
    CSI 0.4
    rCSI 0.9%
    PRS 36.0%
  • retinal ganglion cell CL0000740
    CSI 0.4
    rCSI 0.8%
    PRS 8.9%
  • bronchiolar smooth muscle cell CL4033017
    CSI 0.4
    rCSI 6.1%
    PRS 38.5%
  • amacrine cell CL0000561
    CSI 0.4
    rCSI 1.3%
    PRS 9.6%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 0.4
    rCSI 1.3%
    PRS 18.0%
  • acinar cell of salivary gland CL0002623
    CSI 0.5
    rCSI 10.7%
    PRS 22.1%
  • IgM plasma cell CL0000986
    CSI 0.5
    rCSI 2.2%
    PRS 54.8%
  • myoepithelial cell CL0000185
    CSI 0.5
    rCSI 1.3%
    PRS 15.4%
  • follicular dendritic cell CL0000442
    CSI 0.5
    rCSI 8.6%
    PRS 58.3%
  • tracheal goblet cell CL1000329
    CSI 0.6
    rCSI 1.2%
    PRS 25.0%
  • cerebral cortex pyramidal neuron CL4023111
    CSI 0.6
    rCSI 3.4%
    PRS 34.0%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 0.6
    rCSI 2.1%
    PRS 7.4%
  • mesenchymal lymphangioblast CL0005021
    CSI 0.6
    rCSI 14.7%
    PRS 54.6%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 0.6
    rCSI 0.7%
    PRS 17.3%
  • myeloid dendritic cell CL0000782
    CSI 0.6
    rCSI 0.9%
    PRS 18.2%
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 0.7
    rCSI 1.7%
    PRS 11.5%
  • mononuclear phagocyte CL0000113
    CSI 0.7
    rCSI 1.5%
    PRS 13.7%
  • neuroplacodal cell CL0000032
    CSI 0.7
    rCSI 6.3%
    PRS 36.4%
  • midbrain dopaminergic neuron CL2000097
    CSI 0.7
    rCSI 4.5%
    PRS 18.8%
  • podocyte CL0000653
    CSI 0.7
    rCSI 3.2%
    PRS 12.2%
  • ionocyte CL0005006
    CSI 0.7
    rCSI 0.8%
    PRS 11.4%
  • intraepithelial lymphocyte CL0002496
    CSI 0.8
    rCSI 2.0%
    PRS 48.9%
  • cord blood hematopoietic stem cell CL2000095
    CSI 0.8
    rCSI 14.4%
    PRS 70.2%
  • CD34-positive, CD56-positive, CD117-positive common innate lymphoid precursor, human CL0001074
    CSI 0.8
    rCSI 9.0%
    PRS 46.3%
  • renal intercalated cell CL0005010
    CSI 0.8
    rCSI 7.2%
    PRS 72.9%
  • Merkel cell CL0000242
    CSI 0.8
    rCSI 18.8%
    PRS 70.0%
  • pulmonary artery endothelial cell CL1001568
    CSI 0.8
    rCSI 1.1%
    PRS 18.9%
  • Schwann cell CL0002573
    CSI 0.8
    rCSI 2.3%
    PRS 15.0%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.8
    rCSI 2.6%
    PRS 8.4%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.9
    rCSI 1.0%
    PRS 16.5%
  • small pre-B-II cell CL0000954
    CSI 0.9
    rCSI 0.9%
    PRS 25.6%
  • neural progenitor cell CL0011020
    CSI 0.9
    rCSI 4.0%
    PRS 12.1%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 1.0
    rCSI 2.5%
    PRS 9.5%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 1.0
    rCSI 1.0%
    PRS 19.5%
  • forebrain neuroblast CL1000042
    CSI 1.1
    rCSI 11.4%
    PRS 81.1%
  • luminal cell of prostate epithelium CL0002340
    CSI 1.1
    rCSI 5.8%
    PRS 22.3%
  • keratocyte CL0002363
    CSI 1.1
    rCSI 2.6%
    PRS 18.6%
  • ventricular cardiac muscle cell CL2000046
    CSI 1.1
    rCSI 3.8%
    PRS 47.7%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.1
    rCSI 2.0%
    PRS 9.4%
  • OFF-bipolar cell CL0000750
    CSI 1.2
    rCSI 1.6%
    PRS 20.2%
  • alveolar type 1 fibroblast cell CL4028004
    CSI 1.2
    rCSI 1.3%
    PRS 14.2%
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 1.2
    rCSI 2.9%
    PRS 60.8%
  • fibroblast of breast CL4006000
    CSI 1.2
    rCSI 5.2%
    PRS 31.8%
  • B-2 B cell CL0000822
    CSI 1.3
    rCSI 27.0%
    PRS 59.8%
  • renal alpha-intercalated cell CL0005011
    CSI 1.3
    rCSI 1.8%
    PRS 16.4%
  • Kupffer cell CL0000091
    CSI 1.3
    rCSI 3.0%
    PRS 11.9%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 1.4
    rCSI 4.9%
    PRS 6.7%
  • intermediate monocyte CL0002393
    CSI 1.4
    rCSI 2.1%
    PRS 12.2%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 1.4
    rCSI 2.5%
    PRS 16.3%
  • retinal bipolar neuron CL0000748
    CSI 1.4
    rCSI 2.7%
    PRS 8.9%
  • neuroendocrine cell CL0000165
    CSI 1.4
    rCSI 5.6%
    PRS 25.4%
  • T-helper 1 cell CL0000545
    CSI 1.5
    rCSI 2.8%
    PRS 32.8%
  • chondrocyte CL0000138
    CSI 1.5
    rCSI 2.4%
    PRS 10.6%
  • innate lymphoid cell CL0001065
    CSI 1.6
    rCSI 3.2%
    PRS 18.9%
  • class switched memory B cell CL0000972
    CSI 1.6
    rCSI 1.2%
    PRS 20.8%
  • epithelial cell of proximal tubule CL0002306
    CSI 1.6
    rCSI 4.0%
    PRS 12.4%
  • antibody secreting cell CL0000946
    CSI 1.6
    rCSI 7.3%
    PRS 48.4%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 1.7
    rCSI 3.1%
    PRS 26.9%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 1.7
    rCSI 2.4%
    PRS 11.5%
  • sncg GABAergic cortical interneuron CL4023015
    CSI 1.7
    rCSI 2.7%
    PRS 8.0%
  • retinal pigment epithelial cell CL0002586
    CSI 1.7
    rCSI 3.4%
    PRS 13.1%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 1.7
    rCSI 2.3%
    PRS 29.8%
  • basophil CL0000767
    CSI 1.8
    rCSI 3.7%
    PRS 25.1%
  • skeletal muscle satellite stem cell CL0008011
    CSI 1.8
    rCSI 7.9%
    PRS 35.2%
  • periportal region hepatocyte CL0019026
    CSI 1.8
    rCSI 7.0%
    PRS 17.4%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 1.8
    rCSI 4.5%
    PRS 7.1%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.9
    rCSI 3.3%
    PRS 24.8%
  • bronchial goblet cell CL1000312
    CSI 1.9
    rCSI 7.7%
    PRS 27.1%
  • midzonal region hepatocyte CL0019028
    CSI 2.0
    rCSI 4.6%
    PRS 18.9%
  • B-1 B cell CL0000819
    CSI 2.0
    rCSI 51.2%
    PRS 56.3%
  • professional antigen presenting cell CL0000145
    CSI 2.0
    rCSI 7.0%
    PRS 45.9%
  • inflammatory macrophage CL0000863
    CSI 2.1
    rCSI 3.6%
    PRS 24.9%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 2.2
    rCSI 33.5%
    PRS 30.5%
  • hepatic stellate cell CL0000632
    CSI 2.2
    rCSI 8.1%
    PRS 10.5%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 2.3
    rCSI 3.9%
    PRS 7.3%
  • basal cell of epithelium of trachea CL1000348
    CSI 2.3
    rCSI 16.4%
    PRS 37.9%
  • VIP GABAergic cortical interneuron CL4023016
    CSI 2.3
    rCSI 2.8%
    PRS 7.1%
  • fibroblast CL0000057
    CSI 2.4
    rCSI 6.8%
    PRS 58.0%
  • stratified epithelial cell CL0000079
    CSI 2.4
    rCSI 14.9%
    PRS 48.3%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [SNRPF](/details-gene/6636), or Small Nuclear Ribonucleoprotein Polypeptide F, is a protein-coding gene located on chromosome 12q23.1. As a core component of the spliceosome, [SNRPF](/details-gene/6636) plays a fundamental role in pre-mRNA splicing, a critical step in eukaryotic gene expression. Functionally, it is involved in the assembly and function of small nuclear ribonucleoprotein (snRNP) complexes, which are the building blocks of the spliceosome. Expression data indicates that [SNRPF](/details-gene/6636) has the highest significance in highly proliferative and undifferentiated cell populations, particularly hematopoietic progenitor cells, suggesting it is essential for cellular processes requiring high rates of transcription and protein synthesis, such as cell division and differentiation. ## Cellular Roles and Expression Landscape **Overall**, the expression profile of [SNRPF](/details-gene/6636) strongly points to a ubiquitous and essential role in cellular maintenance and proliferation, with particularly high significance in progenitor and stem cell populations. The gene shows its highest Cell Significance Index (CSI) in various hematopoietic progenitors, including [common myeloid progenitor](/details-cell/CL0000049) (CSI: 93.66), [hematopoietic stem cell](/details-cell/CL0000037) (CSI: 85.50), [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 82.16), and [granulocyte monocyte progenitor cell](/details-cell/CL0000557) (CSI: 80.53). This pattern extends to other highly active cell types, such as [stem cell](/details-cell/CL0000034), [keratinocyte](/details-cell/CL0000312), and rapidly dividing epithelial cells like [fallopian tube secretory epithelial cell](/details-cell/CL4030006) and [intestinal epithelial cell](/details-cell/CL0002563). This suggests that the high metabolic and transcriptional activity characteristic of these cells necessitates robust splicing machinery, making [SNRPF](/details-gene/6636) a key operational gene in these contexts. Conversely, the gene's significance is notably low or negative in terminally differentiated, often quiescent, cell types. These anti-markers include specialized secretory cells like [nasal mucosa goblet cell](/details-cell/CL0002480) (CSI: -7.93), structural cells like [vascular associated smooth muscle cell](/details-cell/CL0000359), and post-mitotic cells such as [central nervous system neuron](/details-cell/CL2000029). The low expression in mature immune effector cells, including [alveolar macrophage](/details-cell/CL0000583) and [CD8-positive, alpha-beta cytotoxic T cell](/details-cell/CL0000794), further supports the hypothesis that its primary role is tied to proliferation and development rather than the specialized functions of differentiated cells. ## Pathways and Molecular Function The functional annotations for [SNRPF](/details-gene/6636) confirm its central role in RNA processing. Gene Ontology (GO) terms place it squarely within the spliceosome, participating in '[Mrna splicing, via spliceosome](/details-go/GO:0000398)' and '[Spliceosomal snrnp assembly](/details-go/GO:0000387)'. It is a structural constituent of numerous snRNP complexes, including the [U1 snRNP](/details-go/GO:0005685), [U2 snRNP](/details-go/GO:0005686), [U4 snRNP](/details-go/GO:0005687), and [U5 snRNP](/details-go/GO:0005682), as evidenced by its localization to the '[Spliceosomal complex](/details-go/GO:0005681)' within the '[Nucleus](/details-go/GO:0005634)'. Its molecular functions are defined as '[Rna binding](/details-go/GO:0003723)' and '[Protein binding](/details-go/GO:0005515)', consistent with its role in assembling snRNP complexes through interactions with both snRNAs and other Sm-class proteins [Link](https://doi.org/10.1002/j.1460-2075.1995.tb07199.x). Reactome pathway analysis further details its involvement in '[Metabolism of rna](/details-reactome/R-HSA-8953854)', particularly the '[Mrna splicing - major pathway](/details-reactome/R-HSA-72163)' and '[Processing of capped intron-containing pre-mrna](/details-reactome/R-HSA-72203)'. This fundamental role in gene expression explains its high significance in the rapidly dividing progenitor cells identified in the expression landscape. Additionally, its annotation in pathways such as '[Sars-cov-2 infection](/details-reactome/R-HSA-9694516)' suggests that the host splicing machinery, including [SNRPF](/details-gene/6636), may be co-opted during viral replication. ## Research Directions The expression pattern of [SNRPF](/details-gene/6636)—high in progenitors and low in their differentiated progeny—suggests a critical, regulated role during cellular maturation. Its fundamental function in splicing also positions it as a potential factor in diseases characterized by uncontrolled proliferation, such as cancer. Based on this evidence, several testable hypotheses can be proposed: 1. **Hypothesis on Differentiation:** The downregulation of [SNRPF](/details-gene/6636) is a prerequisite for the terminal differentiation of hematopoietic stem cells. A reduction in overall splicing efficiency may be necessary to stabilize the transcriptome and lock in a mature cellular phenotype by altering the splicing of key lineage-determining factors. 2. **Hypothesis on Oncogenesis:** In rapidly proliferating cancers, particularly acute myeloid leukemia which originates from myeloid progenitors, overexpression or dysregulation of [SNRPF](/details-gene/6636) may promote malignancy by altering the isoform balance of critical oncogenes or tumor suppressors, leading to a state of "splicing addiction." To address the first hypothesis, a key experiment could be designed: * **Experimental Approach:** Utilize a CRISPR interference (CRISPRi) system to achieve targeted, tunable knockdown of [SNRPF](/details-gene/6636) in primary human [hematopoietic stem cells](/details-cell/CL0000037) cultured *in vitro*. These cells would then be induced to differentiate along the myeloid lineage. The progression of differentiation would be monitored using flow cytometry to quantify cell surface markers characteristic of mature myeloid cells (e.g., CD11b, CD14). Concurrently, RNA-sequencing would be performed at multiple time points to assess global changes in alternative splicing events and identify specific transcripts whose processing is dependent on high [SNRPF](/details-gene/6636) levels. **Therapeutic Potential:** As an essential component of the core splicing machinery, global inhibition of [SNRPF](/details-gene/6636) would likely cause significant toxicity to all dividing cells. However, its high expression in progenitor cells suggests that malignancies derived from these populations might be disproportionately dependent on its function. This makes it a potential "non-oncogene addiction" target. As an intracellular protein within a large complex, it is not amenable to antibody-based therapies. A more viable strategy might involve developing RNA-based therapeutics, such as antisense oligonucleotides, to reduce [SNRPF](/details-gene/6636) expression. Such an inhibition-based strategy could selectively target cancer cells that are highly dependent on robust splicing activity for their survival and proliferation.

Genular Protein ID: 1367816488

Symbol: RUXF_HUMAN

Name: Small nuclear ribonucleoprotein F

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 7744013

Title: snRNP Sm proteins share two evolutionarily conserved sequence motifs which are involved in Sm protein-protein interactions.

PubMed ID: 7744013

DOI: 10.1002/j.1460-2075.1995.tb07199.x

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11574479

Title: Purified U7 snRNPs lack the Sm proteins D1 and D2 but contain Lsm10, a new 14 kDa Sm D1-like protein.

PubMed ID: 11574479

DOI: 10.1093/emboj/20.19.5470

PubMed ID: 11991638

Title: Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.

PubMed ID: 11991638

DOI: 10.1017/s1355838202021088

PubMed ID: 12975319

Title: Unique Sm core structure of U7 snRNPs: assembly by a specialized SMN complex and the role of a new component, Lsm11, in histone RNA processing.

PubMed ID: 12975319

DOI: 10.1101/gad.274403

PubMed ID: 14654843

Title: Proteomic characterization of the human centrosome by protein correlation profiling.

PubMed ID: 14654843

DOI: 10.1038/nature02166

PubMed ID: 15146077

Title: The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.

PubMed ID: 15146077

DOI: 10.1261/rna.7320604

PubMed ID: 16314521

Title: Specific sequence features, recognized by the SMN complex, identify snRNAs and determine their fate as snRNPs.

PubMed ID: 16314521

DOI: 10.1128/mcb.25.24.10989-11004.2005

PubMed ID: 18984161

Title: An assembly chaperone collaborates with the SMN complex to generate spliceosomal SnRNPs.

PubMed ID: 18984161

DOI: 10.1016/j.cell.2008.09.020

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 19325628

Title: Crystal structure of human spliceosomal U1 snRNP at 5.5 A resolution.

PubMed ID: 19325628

DOI: 10.1038/nature07851

PubMed ID: 21816274

Title: Structure of a key intermediate of the SMN complex reveals Gemin2's crucial function in snRNP assembly.

PubMed ID: 21816274

DOI: 10.1016/j.cell.2011.06.043

PubMed ID: 21516107

Title: Structure of the spliceosomal U4 snRNP core domain and its implication for snRNP biogenesis.

PubMed ID: 21516107

DOI: 10.1038/nature09956

PubMed ID: 23333303

Title: Structural basis of assembly chaperone-mediated snRNP formation.

PubMed ID: 23333303

DOI: 10.1016/j.molcel.2012.12.009

PubMed ID: 25555158

Title: Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5' splice site recognition.

PubMed ID: 25555158

DOI: 10.7554/elife.04986

PubMed ID: 26912367

Title: Molecular architecture of the human U4/U6.U5 tri-snRNP.

PubMed ID: 26912367

DOI: 10.1126/science.aad2085

PubMed ID: 28502770

Title: An Atomic Structure of the Human Spliceosome.

PubMed ID: 28502770

DOI: 10.1016/j.cell.2017.04.033

PubMed ID: 28781166

Title: Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation.

PubMed ID: 28781166

DOI: 10.1016/j.cell.2017.07.011

PubMed ID: 28076346

Title: Cryo-EM structure of a human spliceosome activated for step 2 of splicing.

PubMed ID: 28076346

DOI: 10.1038/nature21079

PubMed ID: 31799625

Title: Negative cooperativity between Gemin2 and RNA provides insights into RNA selection and the SMN complex's release in snRNP assembly.

PubMed ID: 31799625

DOI: 10.1093/nar/gkz1135

PubMed ID: 32494006

Title: Molecular architecture of the human 17S U2 snRNP.

PubMed ID: 32494006

DOI: 10.1038/s41586-020-2344-3

PubMed ID: 33509932

Title: Structure of the activated human minor spliceosome.

PubMed ID: 33509932

DOI: 10.1126/science.abg0879

PubMed ID: 36797247

Title: Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly.

PubMed ID: 36797247

DOI: 10.1038/s41467-023-36489-x

Sequence Information:

  • Length: 86
  • Mass: 9725
  • Checksum: 416B88D575DAE58A
  • Sequence:
  • MSLPLNPKPF LNGLTGKPVM VKLKWGMEYK GYLVSVDGYM NMQLANTEEY IDGALSGHLG 
    EVLIRCNNVL YIRGVEEEEE DGEMRE